Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review

The role for PD-1/PD-L1 and CTLA-4 targeted immunotherapy is well outlined in the treatment of metastatic NSCLC. Increased survival benefit supports the use of these medications and the development of next-generation agents with improved efficacy and favorable side-effect profiles. The prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vartanov, Alexander, Kalotra, Aditi, Varughese, Jasmine, Gautam, Shovendra, Kandel, Sean, Hosmer, Wylie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994778/
https://www.ncbi.nlm.nih.gov/pubmed/33786301
http://dx.doi.org/10.1016/j.rmcr.2021.101390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994778/
https://www.ncbi.nlm.nih.gov/pubmed/33786301
http://dx.doi.org/10.1016/j.rmcr.2021.101390

Ejemplares similares